Autogynephilia:The Study Activists Wanted Buried - Dr. Ray Blanchard (#41)
Dr. Ray Blanchard spent fifteen years at a gender identity clinic before publishing work that would reshape — and then be erased from — mainstream gender medicine. His concept of autogynephilia described a distinct erotic pathway to male-to-female transsexualism, one that activists later worked to suppress. For British audiences, the suppression of Blanchard's typology is directly relevant: NHS clinics, including the Tavistock, operated within guidelines that sidelined his framework, and the Cass Review's findings about inadequate evidence may partly reflect the cost of that ideological filtering.
Dr. Ray Blanchard spent fifteen years working at a gender identity clinic, and the research he developed there became some of the most scientifically influential — and politically explosive — work in the history of gender medicine. His 1989 paper gave a name and a definition to autogynephilia: a male's sexual arousal at the thought or image of himself as a woman. This was not, Blanchard argued, the same as cross-dressing. It was a distinct erotic orientation — and understanding it was essential to understanding one of two separate pathways by which males pursued transition. That two-pathway typology gave clinicians a framework for differentiating presentations that looked superficially similar but were rooted in fundamentally different experiences. For years it shaped serious academic work in sexology. Then it became a target. Trans activists argued that the concept was pathologising and harmful, and those arguments found a willing audience inside the medical institutions that were rapidly expanding gender services. The question this episode asks is whether the clinical establishment revised its position because the science demanded it, or because the politics did. For British listeners, this is not a distant academic dispute. NHS gender clinics, including the Gender Identity Development Service at the Tavistock — closed in 2023 following mounting concerns about the quality of its clinical practice — operated within guidelines that had progressively sidelined Blanchard's typology. The Cass Review, whose final report in 2024 reshaped the NHS's approach to gender medicine, found the evidence base underpinning existing practice to be dangerously thin. Part of the reason for that thinness, critics argue, is that research considered politically inconvenient was never properly integrated into clinical training or decision-making. Blanchard's conversation with Stella O'Malley, Mia Hughes and Dr. Bret Alderman is part of the Original Gender Rebels series — a deliberate effort to give platform to researchers whose work was pushed to the margins of a field increasingly shaped by activist pressure rather than scientific rigour. His account of how a clinically grounded research programme became the subject of suppression campaigns speaks directly to the questions the Cass Review raised about ideological capture within gender medicine — questions that have since become central to public and parliamentary debate in the United Kingdom. As the NHS builds replacement gender services in England and Wales, the decisions being made now about which evidence informs those services will have long-term consequences for patients. Whether Blanchard's typology is engaged with seriously, or quietly continued to be ignored, is one indicator of whether reformed services will be genuinely evidence-based or simply a continuation of the same ideological settlement in a different institutional form. This episode makes the case for taking his work seriously — and asks what British healthcare has already paid for failing to do so.
